Digital Health Investment Weekly Report Vol.172 Highlights Key Global Funding Rounds and Strategic Partnerships

Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the official account homepage to get the latest trends and expert insights in the digital healthcare industry第一时间!

01 Global Digital Health Investment and Financing Overview

Healthcare provider Manipal Health Enterprises secures $617 million in funding

On July 16, healthcare service provider Manipal Health Enterprises secured funding of 53 billion rupees (approximately $617 million) from a global banking consortium that included Deutsche Bank, Barclays Bank, and others. The funds will primarily be used to finance its acquisition of Sahyadri Hospitals for 64 billion rupees. Through this acquisition, Manipal Hospitals will significantly expand its network, covering 49 hospitals across China with over 12,000 beds.

Medical Artificial Intelligence Technology Researcher OpenEvidence Secures $210 Million in Series B Funding

On July 15, medical artificial intelligence technology researcher OpenEvidence secured a $210 million Series B financing round, co-led by Google Ventures and Kleiner Perkins, with Sequoia Capital following on, and Coatue, Conviction, and Thrive participating. OpenEvidence's platform is actively used by over 10,000 hospitals and medical centers across China, and more than 40% of doctors in the U.S. log in daily to make high-risk clinical decisions at the point of care.

Medical Financial Services Provider Panacea Financial Secures $62 Million in Series B Funding

On July 16, Panacea Financial, a medical financial services provider, secured a $62 million Series B funding round led by Valar Ventures. The funds will be used to further expand its vertically integrated digital platform, which currently includes banking, lending, legal, and consulting services, and to accelerate the development of smart tools that leverage its proprietary data to personalize and streamline financial decision-making for doctors and their practices.

Alzheimer's Disease Therapy Developer Illimis Therapeutics Secures $42 Million in Series B Funding

On July 14, Alzheimer's disease therapy developer Illimis Therapeutics secured a $42 million Series B financing round, led by eight existing investors including DSC Investment and ten new investors such as LB Investment. The company’s strength lies in its proprietary GAIA (Gas6-mediated Anti-inflammatory Adaptor Protein) platform. The funds will be used to accelerate the development of Alzheimer's disease treatments based on GAIA, expand its target indications to various immune diseases, and broaden the potential pipeline of drug candidates.

Liquid Biopsy Technology Researcher Aqtual Secures $31 Million in Series B Funding

On July 10, liquid biopsy technology researcher Aqtual secured $31 million in Series B funding, led by three new investors including Bold Capital, alongside existing investors such as Genoa Ventures. The funds will be used to expand its novel cell-free circulating DNA (cfDNA) platform, the first technology to integrate DNA, epigenetic regulation, and protein-DNA binding in a single blood test, enabling high-fidelity quantification of tissue-specific gene regulation directly from blood.

Male Reproductive Testing Product Developer Fellow Health Secures $24 Million in Series B Funding

On July 16, Fellow Health, a developer of male reproductive testing products, secured $24 million in Series B funding, led by 5AM Ventures with new participation from The Forest Road Company. The funds will be used to expand the mail-in semen analysis business and broaden its market product line, accelerating Fellow Health's extension of its mail-in semen analysis services, including fertility and post-vasectomy testing.

Brain Tumor Targeted Therapy Developer GT Medical Technologies Secures $16 Million in Series D Equity Financing

On July 15, GT Medical Technologies, a developer of targeted therapies for brain tumors, secured $16 million in Series D equity financing from investors including FemHealth Ventures and Warren Point Capital. The funds will be used to accelerate the commercial expansion and clinical trials of the GammaTile brain tumor treatment technology.

Neurostimulator Developer Comphya Secures CHF 7.5 Million in Financing

On July 12, neurostimulator developer Comphya secured CHF 7.5 million in funding. This round of financing will primarily be used to carry out the FIM clinical study in the United States and the subsequent pivotal U.S. clinical study, as well as to expand clinical research in Australia.

CT Imaging Solutions Provider Tomoverse Imaging Secures $3.65 Million in Funding

On July 14, Tomoverse Imaging, a CT imaging solutions provider, secured $3.65 million in funding, led by a Canadian family office. The funds will be used to support the company’s clinical trials, obtain approvals from Health Canada, the U.S. Food and Drug Administration (FDA), and other global regulatory bodies, and enhance its commercialization efforts in North America and key international markets.

Ultrasound Solutions Provider Scanvio Secures $3.4 Million in Seed Funding

On July 15, Scanvio, an ultrasound solutions provider, secured $3.4 million in seed funding from renowned angel investors and family offices in Switzerland and Germany. The funds will be used for the early diagnosis of endometriosis, further product development, creating the world’s largest labeled dataset of transvaginal ultrasound images, and advancing the regulatory approval process in compliance with FDA and MDR guidelines.

ECMO Medical Device Developer CDX Medical Technologies Secures $2.5 Million in Series A Funding

On July 14, CDX Medical Technologies, an ECMO medical device developer, secured $2.5 million in Series A funding led by Joe Kiani, founder of Masimo, with participation from industry executives and members of the CDX board. The funds will be used to complete regulatory testing, obtain market approval, and launch the commercialization of innovative extracorporeal membrane oxygenation (ECMO) pumps.

JD Health Collaborates with Innovent Biologics to Create a New Ecosystem for Full-Chain Weight Loss and Blood Sugar Reduction Services

On July 14, JD Health and Innovent Biologics Group signed a strategic cooperation agreement. The two parties will engage in in-depth cooperation in multiple areas such as supply chain, omnichannel sales, and digital marketing, providing consumers with a variety of high-quality medicines and health services. In the future, the two parties will focus on promoting patient health education, collaborating with industry experts and authoritative institutions to jointly produce and release health knowledge content on topics such as weight loss and blood sugar reduction. They will also integrate online and offline multi-channel resources to disseminate this information to the public, enhancing general awareness and scientific understanding of metabolic diseases and related medications.

Jianjia Medical and Fosun United Health Insurance Reach Direct Payment Cooperation

On July 14, Jianjia Medical and Fosun United Health Insurance reached a direct payment cooperation agreement. By integrating resources and upgrading services, they aim to provide more efficient and convenient rehabilitation medical services for high-end medical insurance customers, addressing issues such as cumbersome fee advances and complex claims processes, thereby enhancing the rehabilitation experience for patients. Meanwhile, Jianjia Medical has also established an integrated premium service system for mid-to-high-end service customers and upgraded its patient service platform to offer one-stop services.

Tencent Health Collaborates with Kangmei Pharmaceutical: Technological Innovation Accelerates the Modernization of Traditional Chinese Medicine

On July 11, Tencent Health and Kangmei Pharmaceutical reached a strategic cooperation. Both parties will leverage their respective strengths to jointly create an integrated solution for the traditional Chinese medicine (TCM) industry. They will engage in in-depth collaboration across TCM production, manufacturing, marketing, and operations, including co-building a large TCM model and launching the "TCM Brain," to advance the intelligent upgrade and digital development of TCM, supporting the modernization process of the industry.

Life-saving Equipment Provider Safe Life Acquires HTM Medico

On July 15, Safe Life, a provider of life-saving equipment, acquired HTM Medico, a distributor of automated external defibrillators (AEDs). This acquisition marks Safe Life's official entry into the Asian market, particularly the Asia-Pacific region. HTM Medico has established a strong brand presence in the Singapore market and has played a significant role in raising public awareness of life-saving measures during sudden cardiac arrest and improving public access to AEDs over the past two decades.

Professional Nursing Service Provider Encore Wound Care Acquires Pinnacle Care Providers' Wound Care Division 

On July 9, Encore Wound Care, a professional wound care service provider, acquired the wound care division of Pinnacle Care Providers, a post-acute care service provider. This strategic move significantly expanded Encore's specialized wound care services, improved patient accessibility, and solidified its position as a leading provider. Pinnacle's established presence in the long-term care sector enhanced Encore's geographic coverage and clinical capabilities.

ArteryNet/Arterial Orange Industry Think Tank/China Renaissance/China Grand Health/Rock Health/Mobile Health News/Fierce Health, etc.

Compiled by: Hou Zhancái, Huáng Chāngjiàn‍‍‍

Share

Like

Click to view